Literature DB >> 3755603

Reflex sympathetic dystrophy syndrome: an unusual mode of presentation of osteomalacia.

J P Huaux, J Malghem, B Maldague, J P Devogelaer, W Esselinckx, H Withofs, C Nagant de Deuxchaisnes.   

Abstract

We report 2 patients with reflex sympathetic dystrophy syndrome (RSDS) associated with renal tubular osteomalacia. In both patients, RSDS was the presenting manifestation. Treatment of the underlying condition with calcitriol resulted in healing in both patients. These cases prompted us to undertake a retrospective study of 24 consecutive patients with osteomalacia (6 of renal tubular origin, 18 related to vitamin D deficiency), and of 259 consecutive patients with RSDS. Among those with osteomalacia, radiologic lesions strongly suggestive of RSDS were found in 5 patients (21%), 4 of whom had renal tubular defects, and only 1 had vitamin D deficiency. In the group with RSDS, 1 patient (0.4%) was found to have osteomalacia of renal tubular origin. Thus, radiologic findings suggestive of RSDS are frequent in patients with osteomalacia, especially that of renal tubular origin. On rare occasions, the full-blown clinical picture of RSDS may obscure the diagnosis of osteomalacia.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3755603     DOI: 10.1002/art.1780290717

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  3 in total

1.  Reflex sympathetic dystrophy syndrome with microtrabecular fracture in a patient with osteogenesis imperfecta.

Authors:  R Neri; A Martini; D Trippi; V Zampa; G Pasero
Journal:  Clin Rheumatol       Date:  1997-06       Impact factor: 2.980

Review 2.  Osteopenia, bone fragility and reflex sympathetic dystrophy syndrome in a man with ureterosigmoidostomy.

Authors:  B R Lauwerys; J P Dufour; H Noël; B Vande Berg; J P Devogelaer
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

3.  Skeletal manifestations of moderate phosphate diabetes.

Authors:  M Laroche; J Arlet; J L Ader; D Durand; T Tran-Van; B Mazières
Journal:  Clin Rheumatol       Date:  1993-06       Impact factor: 2.980

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.